Evidence map›Paper›PMID 39503904›Full record

ArticleClinical rheumatology2025

Interplay of calcium pyrophosphate crystals, oxidative stress, and clinical features on knee osteoarthritis severity.

Javier Fernández-Torres, Karina Martínez-Flores, Indira Xiomara Puerta-Escalante, Nathalie Montaño-Armendariz, Carlos Suárez-Ahedo, Víctor Ilizaliturri-Sánchez, Rolando Espinosa-Morales, Carlos Alberto Lozada-Pérez, Yessica Zamudio-Cuevas

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Javier Fernández-TorresLaboratorio de Líquido Sinovial, Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Alcaldía Tlalpan, Calzada México-Xochimilco 289, C.P. 14389, Mexico City, Mexico.ORCID http://orcid.org/0000-0002-7271-2862
Karina Martínez-FloresLaboratorio de Líquido Sinovial, Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Alcaldía Tlalpan, Calzada México-Xochimilco 289, C.P. 14389, Mexico City, Mexico.ORCID http://orcid.org/0000-0003-0675-0227
Indira Xiomara Puerta-EscalanteDivisión de Reumatología, Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Alcaldía Tlalpan, Calzada México-Xochimilco 289, C.P. 14389, Mexico City, Mexico.
Nathalie Montaño-ArmendarizDivisión de Reconstrucción Articular Cadera-Rodilla, Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Alcaldía Tlalpan, Calzada México-Xochimilco 289, C.P. 14389, Mexico City, Mexico.ORCID http://orcid.org/0000-0002-6330-8147
Carlos Suárez-AhedoDivisión de Reconstrucción Articular Cadera-Rodilla, Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Alcaldía Tlalpan, Calzada México-Xochimilco 289, C.P. 14389, Mexico City, Mexico.ORCID http://orcid.org/0000-0001-9766-2411
Víctor Ilizaliturri-SánchezDivisión de Reconstrucción Articular Cadera-Rodilla, Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Alcaldía Tlalpan, Calzada México-Xochimilco 289, C.P. 14389, Mexico City, Mexico.ORCID http://orcid.org/0009-0002-9080-4792
Rolando Espinosa-MoralesDivisión de Reumatología, Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Alcaldía Tlalpan, Calzada México-Xochimilco 289, C.P. 14389, Mexico City, Mexico.ORCID http://orcid.org/0000-0002-3923-6956
Carlos Alberto Lozada-PérezDivisión de Reumatología, Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Alcaldía Tlalpan, Calzada México-Xochimilco 289, C.P. 14389, Mexico City, Mexico.ORCID http://orcid.org/0000-0001-8809-6526
Yessica Zamudio-CuevasLaboratorio de Líquido Sinovial, Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Alcaldía Tlalpan, Calzada México-Xochimilco 289, C.P. 14389, Mexico City, Mexico. yesszamudio@gmail.com.ORCID http://orcid.org/0000-0003-1751-3454

Funding

Financiamiento de Proyectos Investigación Para la Salud FPIS 2023-INR-6975
6 · The paper itself

Abstract

backgroundDeposition of calcium pyrophosphate (CPP) crystals is observed in most joints affected by severe osteoarthritis (OA). CPP may cause local damage by inducing an inflammatory process and oxidative stress (OS).

objectivesTo evaluate inflammation and OS induced by CPP deposition and their association with the degree of knee OA.

methodsSynovial fluid (SF) from patients with OA classified as grade 3 and 4 (ACR criteria) was analyzed. Reactive oxygen species (ROS) and H

resultsFifty-six SF were analyzed, 22 (39.28%) were in moderate OA and 34 (60.71%) in severe OA. CPPs were identified in 17 moderate OA and 18 severe OA samples. In the moderate OA, ROS levels were significantly higher in the CPP + group (5.0% vs 2.0%, P = 0.03). Body mass index and CPP were significantly correlated (r =  - 0.439, P = 0.041). In the severe OA group, there were significant correlations of age with WBC (r =  - 0.431, P = 0.011), WBC with H

conclusionROS and inflammation may be factors that potentiate damage in knee OA, and this may help in the development of antioxidant interventions for CPP-associated OA. Key Points • This study evaluated CPP crystal-induced oxidative stress and inflammation and their effect on OA severity. • In the moderate OA phenotype, CPP crystals modify ROS levels. • ROS and inflammation are factors that increase damage in knee OA, especially when CPP crystals are present.

Indexed as

Calcium PyrophosphateOsteoarthritis, KneeOxidative StressSynovial FluidAgedFemaleHumansHydrogen PeroxideInflammationLeukocyte CountMaleMiddle AgedReactive Oxygen SpeciesSeverity of Illness IndexCalcium PyrophosphateHydrogen PeroxideReactive Oxygen SpeciesCalcium pyrophosphate crystalsInflammationKnee osteoarthritisOxidative stress

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.